Manufacturer record

Biogenetic Drugs Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

13 batches manufactured by Biogenetic Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2019 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

13 records linked to Biogenetic Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
13Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2019 to Mar 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

13
NSQ batches since 2019
6
Products affected
Dissolution
Most common failure
Mar 2026
Latest alert

Flagged batches per year

2019 · 32022 · 12025 · 62026 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Iron & Folic Acid Syrup IP 740525-BKN20Mfg 2025-05 · Exp 2027-04 DescriptionDescription RDTL, Bellary, KarnatakaState lab Mar 2026
Iron & Folic Acid Syrup IP 880525-BKN20Mfg 2025-05 · Exp 2027-04 Test for pH and Assay for Elemental IronAssay DTL, Bengaluru, KarnatakaState lab Jan 2026
Iron & Folic Acid Syrup IP 1340625-BKN20Mfg 2025-06 · Exp 2027-05 Test for DissolutionDissolution DTL, Bengaluru, KarnatakaState lab Jan 2026
Albendazole Tablets IP 400 mg 010625-BTP3Mfg 2025-06 · Exp 2027-05 DissolutionDissolution State Drugs Testing Laboratory, Govt. of Tripura, AgartalaCDSCO lab Aug 2025
Ibuprofen TabletsIP 400 mg 060124-BKN13Mfg 2024-01 · Exp 2025-12 DescriptionDescription KarnatakaState lab Jul 2025
Ibuprofen TabletsIP 200 mg 020125-BCG01Mfg 2025-01 · Exp 2026-12 DissolutionDissolution Drug Control Department ChhattisgarhState lab Jul 2025
Ibuprofen Tablets IP 400mg 290524-BKN13Mfg 2024-05 · Exp 2026-04 Test for DissolutionDissolution KarnatakaState lab Jul 2025
Ibuprofen Tablets IP 400 mg 270524-BKN13,Mfg 2024-05 · Exp 2026-04 Dissolution of IbuprofenDissolution State Lab KarnatakaState lab Jun 2025
Ibuprofen Tablets IP 400 mg 310524-BKN13Mfg 2024-05 · Exp 2026-04 Dissolution of IbuprofenDissolution State Lab KarnatakaState lab Jun 2025
Aluminium Hydroxide, Magnesium Trisilicate and Activated Polydimethylsiloxan e Suspension (Liquid Antacid) 010122-BTN13Mfg 2022-01 · Exp 2023-12 AssayAssay CDTL ChennaiCDSCO lab Aug 2022
Ibuprofen Tablets I.P. 400 mg. 01019-BJA36Mfg 2019-01 · Exp 2020-12 DissolutionDissolution RDTL GuwahatiState lab Nov 2019
Ibuprofen Tablets I.P. 400 mg 01019-BJA36Mfg 2019-01 · Exp 2020-12 DissolutionDissolution RDTL GuwahatiState lab Oct 2019
Ciprofloxacin Tablets IP 500 Mg 05028-BTN21Mfg 2018-02 · Exp 2020-01 DissolutionDissolution CDTL ChennaiCDSCO lab Sep 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.